SCHEMBL29779778

SCHEMBL29779778

CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC1=O

nearest known ligand 0.55

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.52
ABCB1 P08183 1/20 0.52
ST14 Q9Y5Y6 1/20 0.51
ITGB3 P05106 1/20 0.48
ITGB1 P05556 1/20 0.48
ITGAV P06756 1/20 0.48
ITGA5 P08648 1/20 0.48
ITGB5 P18084 1/20 0.48
HDAC4 P56524 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28240936 1.00 GHSR (0.52) GHSRABCB1ST14ITGB3ITGB1
SCHEMBL29779774 0.89 ST14 (0.49) GHSRST14
SCHEMBL29220474 0.89 ABCB1 (0.55) GHSRABCB1HDAC4
SCHEMBL29779763 0.88 ABCB1 (0.51) GHSRABCB1
SCHEMBL1773188 0.88 ELANE (0.50) ST14
SCHEMBL29387556 0.87 ABCB1 (0.57) GHSRABCB1HDAC4
Cyclolinopeptide A SCHEMBL31609181 0.86 ABCB1 (0.54) ABCB1HDAC4
SCHEMBL29711439 0.84 ABCB1 (0.52) ABCB1HDAC4
SCHEMBL29711638 0.84 ABCB1 (0.53) ABCB1
Stylopeptide SCHEMBL31094295 0.84 HDAC4 (0.53) ABCB1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025087637-A1 PSEUDOSTELLARIA HETEROPHYLLA ROOT EXTRACT AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2025-05-01 WO claimed
CN-122031343-A Composition with pouch removing effect, eye cream containing composition and preparation method of eye cream 马应龙大健康有限公司 2026-05-15 CN disclosed
CN-122005506-A Intestinal patch loaded with radix pseudostellariae cyclopeptide B and preparation method and application thereof 贵州医科大学 2026-05-12 CN disclosed
CN-120424113-A Soluble hydrazino functional carrier and preparation method and application thereof 南京工业大学 2025-08-05 CN disclosed
CN-120137797-A Eurotium cristatum of high-yield cellulase system and application of eurotium cristatum in improving drug effect and improving flavor by fermenting Chinese herbal medicines 福州大学 2025-06-13 CN disclosed
US-20250164468-A1 Method for Cellular Lifespan Measurement AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2025-05-22 US disclosed
US-20250161338-A1 Compounds for Anti-aging Intervention AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2025-05-22 US disclosed
CN-119950345-A Anti-wrinkle face cream 广东丸美生物技术股份有限公司 2025-05-09 CN disclosed
CN-119950346-A New application of pseudostellaria root cyclic peptide B 深圳市维琪科技股份有限公司 2025-05-09 CN disclosed
WO-2025087637-A1 PSEUDOSTELLARIA HETEROPHYLLA ROOT EXTRACT AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2025-05-01 WO disclosed
CN-118873430-B Plant A alcohol wrinkle-removing tightening composition suitable for sensitive muscles and application thereof 诺德溯源(广州)生物科技有限公司 2025-04-04 CN disclosed
CN-119607175-A Application of Nidamib and plant-derived cyclic peptide combined drug in preparation of drug for treating pulmonary fibrosis 中国药科大学 2025-03-14 CN disclosed
CN-119246748-A Method for establishing radix pseudostellariae medicinal material fingerprint spectrum 江中药业股份有限公司 2025-01-03 CN disclosed
EP-4479548-A2 METHOD FOR CELLULAR LIFESPAN MEASUREMENT Agency for Science, Technology and Research (SG) 2024-12-25 EP disclosed
CN-119139451-A Application of radix pseudostellariae cyclic peptide B in antithrombotic medicines 南通大学 2024-12-17 CN disclosed
CN-119020439-A Preparation method for in-vitro biosynthesis of pseudostellaria root cyclic peptide B 广州环亚化妆品科技股份有限公司 2024-11-26 CN disclosed
CN-118873430-A Plant A alcohol wrinkle-removing tightening composition suitable for sensitive muscles and application thereof 诺德溯源(广州)生物科技有限公司 2024-11-01 CN disclosed
CN-118006700-A Synthesis method of radix pseudostellariae cyclic peptide B 润辉生物技术(威海)有限公司 2024-05-10 CN disclosed
WO-2023158383-A2 METHOD FOR CELLULAR LIFESPAN MEASUREMENT AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-08-24 WO disclosed
CN-114720568-A Method for establishing fingerprint spectrum of radix pseudostellariae medicinal material and application thereof 云南雷允上理想药业有限公司 2022-07-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250161338-A1 Compounds for Anti-aging Intervention GLA, SIRT1, TFAM GHSR 1982/4885ABCB1 4598/4885ST14 2646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.